Literature DB >> 25679121

A quantitative measure of handwriting dysfluency for assessing tardive dyskinesia.

Michael P Caligiuri1, Hans-Leo Teulings, Charles E Dean, James B Lohr.   

Abstract

Tardive dyskinesia (TD) is a movement disorder commonly associated with chronic exposure to antidopaminergic medications, which may be in some cases disfiguring and socially disabling. The consensus from a growing body of research on the incidence and prevalence of TD in the modern era of antipsychotics indicates that this disorder has not disappeared continues to challenge the effective management of psychotic symptoms in patients with schizophrenia. A fundamental component in an effective strategy for managing TD is its reliable and accurate assessment. In the present study, we examined the clinical utility of a brief handwriting dysfluency measure for quantifying TD. Digitized samples of handwritten circles and loops were obtained from 62 psychosis patients with or without TD and from 50 healthy subjects. Two measures of dysfluent pen movements were extracted from each vertical pen stroke, including normalized jerk and the number of acceleration peaks. Tardive dyskinesia patients exhibited significantly higher dysfluency scores than non-TD patients and controls. Severity of handwriting movement dysfluency was correlated with Abnormal Involuntary Movement Scale severity ratings for some tasks. The procedure yielded high degrees of test-retest reliability. These results suggest that measures of handwriting movement dysfluency may be particularly useful for objectively evaluating the efficacy of pharmacotherapeutic strategies for treating TD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25679121      PMCID: PMC4344392          DOI: 10.1097/JCP.0000000000000277

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  30 in total

1.  Parkinsonism reduces coordination of fingers, wrist, and arm in fine motor control.

Authors:  H L Teulings; J L Contreras-Vidal; G E Stelmach; C H Adler
Journal:  Exp Neurol       Date:  1997-07       Impact factor: 5.330

2.  Tardive dyskinesia: therapeutic options for an increasingly common disorder.

Authors:  Leslie J Cloud; Deepti Zutshi; Stewart A Factor
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

3.  The death of specificity in psychiatry: cheers or tears?

Authors:  Charles E Dean
Journal:  Perspect Biol Med       Date:  2012       Impact factor: 1.416

4.  A rating scale for drug-induced akathisia.

Authors:  T R Barnes
Journal:  Br J Psychiatry       Date:  1989-05       Impact factor: 9.319

5.  Effects of amantadine on tardive dyskinesia: a randomized, double-blind, placebo-controlled study.

Authors:  Sofia Pappa; Sofia Tsouli; George Apostolou; Venetsanos Mavreas; Spiridon Konitsiotis
Journal:  Clin Neuropharmacol       Date:  2010 Nov-Dec       Impact factor: 1.592

6.  Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study.

Authors:  Scott W Woods; Hal Morgenstern; John R Saksa; Barbara C Walsh; Michelle C Sullivan; Roy Money; Keith A Hawkins; Ralitza V Gueorguieva; William M Glazer
Journal:  J Clin Psychiatry       Date:  2010-02-09       Impact factor: 4.384

Review 7.  Tardive dyskinesia and new antipsychotics.

Authors:  Christoph U Correll; Eva M Schenk
Journal:  Curr Opin Psychiatry       Date:  2008-03       Impact factor: 4.741

8.  Handwriting analysis indicates spontaneous dyskinesias in neuroleptic naïve adolescents at high risk for psychosis.

Authors:  Derek J Dean; Hans-Leo Teulings; Michael Caligiuri; Vijay A Mittal
Journal:  J Vis Exp       Date:  2013-11-21       Impact factor: 1.355

Review 9.  Treatment of neurolept-induced tardive dyskinesia.

Authors:  Stacey K Jankelowitz
Journal:  Neuropsychiatr Dis Treat       Date:  2013-09-16       Impact factor: 2.570

10.  Tardive and spontaneous dyskinesia incidence in the general population.

Authors:  Ray M Merrill; Joseph L Lyon; Paul M Matiaco
Journal:  BMC Psychiatry       Date:  2013-05-28       Impact factor: 3.630

View more
  6 in total

1.  Instrument-based assessment of motor function yields no evidence of dyskinesia in adult first-degree biological relatives of individuals with schizophrenia and schizoaffective disorder.

Authors:  Jerillyn S Kent; Michael P Caligiuri; Mallory K Skorheim; Timothy J Lano; Vijay A Mittal; Scott R Sponheim
Journal:  Psychiatry Res       Date:  2018-12-06       Impact factor: 3.222

2.  [Antipsychotic-induced motor symptoms in schizophrenic psychoses-Part 3 : Tardive dyskinesia].

Authors:  D Hirjak; K M Kubera; S Bienentreu; P A Thomann; R C Wolf
Journal:  Nervenarzt       Date:  2019-05       Impact factor: 1.214

3.  Handwriting Movement Abnormalities in Symptomatic and Premanifest Huntington's Disease.

Authors:  Michael Caligiuri; Chase Snell; Sungmee Park; Jody Corey-Bloom
Journal:  Mov Disord Clin Pract       Date:  2019-08-16

4.  Examining Motor Anticipation in Handwriting as an Indicator of Motor Dysfunction in Schizophrenia.

Authors:  Yasmina Crespo Cobo; Sonia Kandel; María Felipa Soriano; Sergio Iglesias-Parro
Journal:  Front Psychol       Date:  2022-04-01

5.  Handwriting training in Parkinson's disease: A trade-off between size, speed and fluency.

Authors:  Evelien Nackaerts; Sanne Broeder; Marcelo P Pereira; Stephan P Swinnen; Wim Vandenberghe; Alice Nieuwboer; Elke Heremans
Journal:  PLoS One       Date:  2017-12-22       Impact factor: 3.240

6.  Correlation of Blood Biochemical Markers with Tardive Dyskinesia in Schizophrenic Patients.

Authors:  Qian Wu; Fengjuan Yuan; Shuo Zhang; Weiting Liu; Qing Miao; Xinhua Zheng; Suxiang Lu; Kaijian Hou
Journal:  Dis Markers       Date:  2022-03-08       Impact factor: 3.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.